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Background: There has been a call for increased patient autonomy and participation in 
psychiatry. Some Community Mental Health Centers (CMHC) have implemented services 
called “self-referral to inpatient treatment” (SRIT) for patients with severe mental disorders.  
Aims: To investigate whether SRIT could yield better outcomes after 12 months in use of 
mental health services for people with severe mental disorders than Treatment As Usual 
(TAU).  
Methods: This was a randomized controlled trial at a CMHC in Norway comparing SRIT and 
TAU in 12 months. 54 patients with severe mental disorders were included. The patients in 
the SRIT group could admit themselves as inpatients for up to 5 days for each admission with 
at least a 2 weeks pause between the admittances.  
Results: Twenty out of 26 participants (77%) in the SRIT group used the SRIT for a median 
of 1.5 admissions and 5 inpatient days. With the exception of a somewhat larger number of 
admissions at the CMHC in the SRIT group, no significant differences were found between 
the 2 groups in days as inpatients, admissions, outpatient contacts or coercion. Both groups 
reduced their inpatients days with 40%.  
Conclusions: Both the SRIT and the TAU groups reduced their use of services during the 12 
months intervention period. Giving patients with severe mental disorders the possibility to 
self-refer did not change the use of services. 
Clinical implications: Self-referral to inpatient treatment for patients with severe mental 
disorders might increase patient autonomy, but do not seem to save use of inpatient services. 
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Models for increased patient autonomy and participation in treatment decisions (1) have been 
implemented both in psychiatry and other medical disciplines throughout the western world 
(2) and their effects documented (3). Increased engagement, knowledge and realistic 
perception of outcomes and higher rating of satisfaction are described both in more acute 
choices of treatment of somatic conditions and in chronic disorders as diabetes. Less progress 
has been made in patient autonomy and participation in treatment of patients with chronic 
psychiatric disorders, especially those with psychotic disorders (4). Schizophrenia and bipolar 
disorder (BD) are among the most costly illnesses in the world and account for a considerable 
share of total health care budgets in developed countries (5-7). A large proportion of the total 
health care costs of schizophrenia and BD are due to hospitalizations (7, 8). Re-
hospitalizations are costly and are markers of reduced function and quality of life of patients 
with psychotic disorders and their families (9-11). Internationally the concept of recovery has 
had a growing influence on mental health services (12) emphasizing patients self-direction, 
empowerment and responsibility (13). One solution to increase the patient participation in 
mental health services is to make it possible for patients to self-refer to inpatient stay in 
mental health services. Several Community Mental Health Centers (CMHC) in Norway have 
implemented services called “self-referral to inpatient treatment” (SRIT) for patients with 
severe mental disorders (14-16). The aims of SRIT are to secure low threshold access to short 
term inpatient admissions and to increase patient participation and involvement in treatment 
choices and decisions (17). There are no RCTs on the effects of SRIT, but one uncontrolled 
study comparing patients before and after inclusion in SRIT, found that over a period of 
approximately 18 months, the number of admissions rose, but the number of days hospitalized 




The aim of this randomized controlled trial was to investigate whether having a contract to 
use SRIT had an effect on use of mental health services, including use of hospital beds, over 
12 months for people with severe mental disorders compared with treatment as usual (TAU) 
which both groups received.  
Our primary hypothesis was that the total number of inpatient days in mental health services 
would be significantly fewer for patients randomized to SRIT compared with TAU over a 12 
month period.  
Secondary hypotheses were that use of admissions and inpatient days at CMHC, psychiatric 
hospital acute wards and use of coercion would be significantly fewer in the SRIT group 
compared with the TAU group as assessed over a 12 month period.  
Materials and methods 
Trial design 
This was an open parallel group randomized controlled trial, with a balanced randomization 
between the SRIT and the TAU group. Written informed consent was obtained prior to 
randomization and the research was carried out in compliance with the Helsinki Declaration. 
The study was approved both by The Regional Committee for Medical and Health Research 
Ethics in Central-Norway (No 2009/1704) and the Norwegian Data Inspectorate and 
registered in Clinicaltrials.gov (NCT 01133587). The inclusion period was between May 2010 
and December 2012. 
Study settings 
The study took place at the Rehabilitation section of Nidaros CMHC in Trondheim, Norway. 
The CMHC has a catchment area with a total of 94 000 inhabitants, two-thirds urban and the 
rest from surrounding rural areas. The CMHC offer both in- and outpatient services including 
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home visits and group activities. Nidaros CMHC is a part of St Olavs University Hospital 
which is the only provider of psychiatric CMHC and hospital inpatient services in the area.  
Participants 
All participants were extensive users of services over at least two years both from primary and 
psychiatric health care and had prior admittance to the rehabilitation section of the trial 
CMHC. Examples of received services were regular or long time admissions, frequent 
supervision from psychiatric nurses, outpatient contacts, and supportive housing residency, 
for details, see Results.  
Patients with severe self-destructive or unrestrained behavior, ongoing drug or alcohol abuse 
or who did not acknowledge the need for or the function of SRIT were excluded. Patients with 
known previous alcohol or drug abuse were not excluded. 
The ICD-10 clinical diagnoses (18) were set according to the routines of the department either 
by a psychiatrist or a senior clinical psychologist before the participants were included in the 
study.  
All participants, except two, were diagnosed with bipolar disorders or schizophrenia, one 
participant was diagnosed with an organic psychosis and one with a personality disorder with 
psychotic features (voice hallucinations).  
  
Recruitment 
Most of the participants were recruited following a stay in the rehabilitation section of the 
CMHC offering SRIT, some were included and randomized while still admitted at the 
CMHC, expected to be discharged in a short time. Written and oral information were given to 
the patients in an information meeting about the study, with an invitation to participate. The 
participants were then contacted through their therapists or other health care personnel at the 
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CMHC. Patients and their relatives could also take direct contact for information and 
enrollment in the program. All participants gave their written consent. All participants had to 
be approved by the chief physician. 
Interventions 
Participants in the intervention group signed a one year contract on “self-referral to inpatient 
treatment” (SRIT). The participants assigned to the SRIT intervention could, at their own 
initiative, admit themselves to the rehabilitation section as inpatients for up to 5 days for each 
admission without referral from a physician or other health care personnel in advance, with a 
mandatory pause of 14 days between admissions. Participants could self-refer to the 
rehabilitation section of the CMHC on Mondays to Fridays between 08:00 and 20:00. This 
was done to avoid capacity problems in the unit and to follow the routines from the first study 
in Norway (14). During the stay, the patients participated in the daily routines of the section, 
but did not receive any specific treatment beyond that as part of the stay, i.e. consultations 
about medications or other mental health related problems.  
Patients in the control group received treatment as usual (TAU) and were offered a contract 
on SRIT one year after inclusion in the study.  All participants, regardless of group allocation, 
had the opportunity to be admitted through regular procedures. TAU consisted of ordinary 
psychosocial and pharmacological treatment including contact with the general practitioner, 
emergency department, or duty doctor if they needed hospitalization. All participants were 
motivated to establish an individual treatment plan describing services they received and what 
to do if symptoms increased in severity, which almost all patients had when they joined the 
study.  
Outcomes  
The primary outcome was inpatient days in any psychiatric department at the university 
hospital or CMHC from baseline to 12 months after inclusion. Secondary endpoints were 
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inpatient days and admissions at the CMHC, both included and excluded SRIT, hospital acute 
and rehabilitation wards and use of coercion. To document the implementation of the 
intervention, number of SRIT admissions, and days admitted were recorded.  The data were 
collected from the patient administrative systems of the hospital trust.  
Sample size 
Sample size was not calculated based on the primary outcome, days as inpatients, but based 
on estimated number of patients that it would be possible to include during the two and a half 
year inclusion period.   
Randomization 
An internet based computerized randomization service from Norwegian University of Science 
and Technology (NTNU) was used for the concealed sequence generation.  Stratification was 
done: Patients were stratified in those who had Psychiatric Ambulatory Rehabilitation Team 
or not. Block randomization was used and all involved in the study were blinded to the size of 
the blocks.  
Blinding 
There were no blinding of results in the study; the results are based on patient administrative 
data.  
Statistical methods 
Data were analyzed according to the intention to treat principle. Parametric tests were used to 
analyze normally distributed continuous data and nonparametric tests to analyze not normally 
distributed data. Categorical data were analyzed using Chi-Square test. ANCOVA was used to 
control for possible effects of covariates. For the within group analysis, paired t-test was used. 





The number of participants assessed for eligibility was not available. 54 participants meeting 
the inclusion criteria were randomized from May 2010 to December 2012. Of the 54 
recruited, one participant withdrew from the project immediately following randomization to 
the control group and was not included in the analysis. Of the remaining 53, one participant in 
the intervention group died 9 months and 9 days after inclusion and one in the control group 
died just short of 6 months after inclusion. Data on deceased participants were included in the 
analysis on an intention to treat basis. See Figure 1. 
<< (Figure 1) >> 
Baseline data 
Baseline demographics and clinical characteristics were similar in both groups apart from 
participants in the intervention group being older. The participants in the intervention group 
had non-significantly more severe scores on all clinical parameters, except for diagnoses, see 
Table 1.  
<< (Table 1) >> 
Implementation of the intervention 
Twenty of 26 participants (77%) in the SRIT group used the opportunity of self-referral and 
had a median of 1.5 admissions and 5 inpatient days during the 12 months SRIT intervention.  
Outcome 
The median number of days as inpatients during 12 months were 39.5 (mean 81.4) days in the 
SRIT group and 33 (mean 66.6) days in the TAU group with a mean difference of 14.7 days 
(Standard Error 23.9 and 95% Confidence Interval -33.2 to 62.7) and p= .54.  
For the secondary outcomes, with the exception of larger number of admissions at CMHC in 
the SRIT group, no significant differences were found between the groups, see Table 2. 
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<< (Table 2) >>  
Analyses of covariance (ANCOVA) controlling for: age (F = .08, p=.78), days hospitalised 
12 months before inclusion (F = .35, p=.56) and inpatient days under coercion the preceding 
year (F = .29, p=.60) showed no significant differences between the intervention and control 
groups in days hospitalised in the 12 months after inclusion. 
  
Ancillary analyses 
A paired t-test for within group changes showed that both groups as a whole had a significant 
reduction in the total number of inpatient days 12 months after randomization compared to 12 
months before randomization (mean = 56.6 days, SD = 145.2, 95% CI = 16.6 – 96.6, p = 
0.006). The mean reduction for the intervention group was 63.3 days (140.8 days before and 
77.5 days after), SD = 156.6, 95 % CI = 0.05 – 126.6, p= .05 and the mean reduction for the 
control group was 50.1 days (113.4 days before and 63.3 days after), SD = 136.1, 95 % CI = - 
3.7 – 103.9, p= .067. 
Discussion 
Synopsis of the key findings 
We found no significant differences in use of psychiatric services between the intervention 
group and the TAU group except for more admissions to the CMCH in the SRIT group. 
Paired t-tests showed a significant reduction (approximately 40%) in the number of days  
admitted 12 months after randomization compared to 12 months before randomization both in 
the intervention group and the control group. To our knowledge, this is the first randomized 
controlled trial on the effects of self-referral to inpatient treatment for patients with severe 
mental disorders.  
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Consideration of possible mechanisms and explanations 
Participants in the intervention group were considerably older than in the control group. Age 
is known to affect prognosis and the extent of use of psychiatric services of patients with 
psychotic disorders (19). An ANCOVA test controlling for age showed however no 
differences between the intervention group and the control group in number of days 
hospitalized 12 months after inclusion. 
All the participants had good access to services, severe illnesses and low function described 
by their diagnoses and the number of days as inpatients the year before inclusion in the study. 
This might explain the lack of effects of a rather limited intervention as SRIT compared to the 
TAU intervention that all the participants in both groups received.  
The present study focused on a limited scope of objective outcomes, and possible effects of 
SRIT on other aspects of recovery were not addressed. (20) (21) (22) Some of these themes 
were analyzed in a qualitative study, based on the same material where a selection of the 
patients was interviewed 4 and 12 months after inclusion in the study (15, 23).  
Due to outliers in use of inpatient days and admissions there is a great difference between the 
median and mean values. 
A possible explanation of the reduction in use of services in both groups might be that 
patients were referred to the trial during a period of exacerbation in their illness, and therefore 
had a higher level of use of services than usual. Thus a normalization of the use of services 
after inclusion may explain some of the reduction during the 12 months intervention period in 
addition to regression to the mean seen in many studies. Another explanation might be the 
effects of increased contact and assessments of patients in both groups during the intervention 
period. A third explanation might be that the patients in the TAU group knew that they would 
have a contract on SRIT one year later.  
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Comparison with relevant findings from other published studies. 
No other RCT´s are found on the effects of SRIT. One uncontrolled study observing patients 
before and after they were included in SRIT found that over a period of approximately 18 
months, the number of admissions rose, but the number of day’s hospitalized and 
hospitalization days by coercion were reduced (14). These results are comparable to our 
findings from within group analyzes showing a reduction in use of services in both the 
intervention and the control groups of 40 % over 12 months. 
Limitations and strengths of the present study 
A limitation of the study is that no prior power calculation could be made based on the main 
outcome as previous data were not available. A sample size of 53 participants might be too 
small to reveal minor differences between the two treatment groups, but major differences 
should be revealed. The cost and resource utilization of the intervention was not compared 
with the standard cost of CMHC-admissions. The patients were not systematically diagnosed 
at inclusion with a diagnostic tool as SCID-I (24), but on clinically based ICD-10 diagnoses 
which had been confirmed over time as the patients had received treatment both as in- and 
out-patients several times before entering the study both at the hospital and CMHC 
department with diagnostic evaluations. The present study measured one objective dimension 
of outcome i.e. use of services while other possible effects of SRIT remain to be evaluated.  It 
might take up to several years to see marked improvement in symptoms in schizophrenia (25), 
therefore a follow up period of 12 months might be short to see long term clinical 
improvements resulting in lesser use of psychiatric services (26). Strengths of the study are 
the randomized controlled design and the objective data on use of services on all patients from 
psychiatric health care services.  
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Clinical and research implications of the work. 
Giving patients with severe mental disorders the possibility to self-refer did not change the 
use of services during the 12 months intervention period compared to TAU. Thus SRIT 
admissions seemed to replace some of the ordinary admissions and give some more autonomy 
to the patients.  Further research is needed on both short- and long term effects of SRIT 
focusing on multiple aspects of recovery before it is possible to conclude about the clinical 
value of this treatment procedure.  
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Assessed for eligibility 
Analysed (n = 26)  
 
Lost to 12 months assessments (n = 0) 
Discontinued intervention (n= 0) 
One died after 9 months 
Allocated to intervention (n = 26) 
 Received allocated intervention (n = 26) 
  
Lost to 12 months assessments (n = 0) 
Discontinued intervention (n= 0) 
One died after 6 months 
 
Allocated to control group (n = 28) 
 Received allocated intervention (n = 27) 
 Did not receive allocated intervention (n=1), 
Withdrew immediately after randomization 
 



















Demographic and clinical characteristics at baseline. 
 
 




Patients N = 53 N = 26 N = 27 
Age, mean (SD) 40.3 (13.0) 45.7 (12.5) 35.2 (11.6) 
Female No. 22 (42%) 12 (46%) 10 (37%) 
Days hospitalized 12 months preceding study entry 72 (31-220.5) 118.5 (26-230.5) 53 (29-157)  
Admissions 12 months preceding study entry 2.87 (1.86) 3.19 (2.14) 2.56 (1.53) 
Days under coercion 12 months preceding study 
entry 
81.77 (133.7) 97.8 (132.5) 66.4 (135.5) 
Participants under coercion 12 months preceding 
study entry 
20 (38%) 13 (50%) 7 (26%) 
Diagnoses ICD 10    
 Schizophrenia and other psychotic disorders  40 (75%) 18 (69%) 22 (81%) 
 Bipolar disorder 13 (25%) 8 (31%) 5 (19%) 






Number of inpatient days, admissions, outpatient contact and use of coercion 12 months 
following study entry, given as median (interquartile 25-75) or numbers with percentage. 






  N=53 N=26 N=27  
Inpatient days     
 All# 34 (11.5-94.5) 39.5 (15.5-84.25) 33 (3-96) .33* 
 SRIT, CMHC, Hospital 33 (11.5-85) 35.5 (15.5-70.25) 33 (3-96) .42* 
 CMHC including SRIT 22 (8-64.5) 29.5 (15.5-62.75) 19 (1-87) .23* 
 Acute ward at hospital 0 (0-7) 0 (0-8.25) 0 (0-6) .56* 
 Acute and rehabilitation ward at 
hospital 
0 (0-7) 0 (0-9.25) 0 (0-6) .61* 
 Community services 0 (0-0) 0 (0-0)   
 SRIT  5 (0-17)   
Admissions     
 All# 3 (1-6.5) 4.5 (1-8) 2 (1-5) .13* 
 SRIT, CMHC, Hospital 3 (1-6.5) 4.5 (1-8) 2 (1-5) .14* 
 CMHC including SRIT 2 ( 1-5) 3 (1-6) 2 (1-3) .02* 
 Acute ward at hospital 0 (0-2) 0 (0-1.3) 0 (0-2) .40* 
 SRIT  1.5 (0-4.25)   
Outpatient consultations     
 All 27 (8.5-60) 26.5 (8.75-60.75) 30 (7-60) .89* 
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Patients admitted     
 SRIT  20 (76.9%)   
 SRIT, CMHC 47 (88.7%) 25 (96.2%) 22 (81.5%) .10 
 Acute ward at hospital 21 (39.6%) 9 (35%) 12 (44.4%) .47 
Patients under coercion 18 (34%) 10 (38%) 8 (30%) .50 
Days under coercion 0 (0-103) 0 (0-148.5) 0 (0-31) .24* 
Analyzed with Mann-Whitney test* or Chi-Square test 
SRIT: Self-referral to inpatient treatment 
CMHC: Community Mental Health Center 
# All include admissions and inpatient days in hospital, SRIT, CMHC, and community 
services. 
 
 
 
